title: Rubella control in France.
abstract: In the pre-vaccination era, rubella was regarded as only a mild exanthematous acute viral infection of children. The devastating effects of the disease were first identified in the early 1940s by an Australian ophthalmologist, and further confirmed during the 1962-65 rubella pandemic in Europe and the United States. They result from the transmission of the virus by infected pregnant women to their fetus. The resulting congenital rubella syndrome (CRS) comprises a lengthy list of abnormalities. The most common ones are deafness, ocular and cardiac defects and mental retardation. The objective of rubella vaccination, to which France has subscribed, is the elimination of CRS.
authors.affiliation: Institut de Veille Sanitaire, Saint-Maurice, France.
authors.forename: D
authors.initials: D
authors.lastname: Lévy-Bruhl
authors.forename: C
authors.initials: C
authors.lastname: Six
authors.forename: IsabelleI
authors.initials: I
authors.lastname: Parent
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D005602:France; D006801:Humans; D007223:Infant; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control; D012409:Rubella / Q000517:prevention & control*; D012411:Rubella Vaccine
chemical_list: D012411:Rubella Vaccine